Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

195 results about "Diastole" patented technology

Diastole /daɪˈæstəliː/ is the part of the cardiac cycle during which the heart refills with blood after the emptying done during systole (contraction). Ventricular diastole is the period during which the two ventricles are relaxing from the contortions/wringing of contraction, then dilating and filling; atrial diastole is the period during which the two atria likewise are relaxing under suction, dilating, and filling. The term diastole originates from the Greek word διαστολή, meaning dilation. Evidence thus provided shows Diastole is not a passive phase.

Paravalvular leak detection, sealing, and prevention

The present invention provides a series of new percutaneous concepts of paravalvular repairs including identifying the leak location, several repair techniques and finally built-in means for leak prevention, built on percutaneous valves. A catheter-delivered device locates cavities occurring between a prosthetic valve and the wall of the body vessel where the valve is implanted, the cavities producing paravalvular leaks during diastole, the device comprising at least one of a plurality of flexible wires, the wire having attached to it a balloon, wherein the balloon is pulled by the leak through the cavity and wherein the wire then serves to mark the cavity location.
Owner:EDWARDS LIFESCI PVT

Systems for heart treatment

Described are devices and methods for treating degenerative, congestive heart disease and related valvular dysfunction. Percutaneous and minimally invasive surgical tensioning structures offer devices that mitigate changes in the ventricular structure (i.e., remodeling) and deterioration of global left ventricular performance related to tissue damage precipitating from ischemia, acute myocardial infarction (AMI) or other abnormalities. These tensioning structures can be implanted within various major coronary blood-carrying conduit structures (arteries, veins and branching vessels), into or through myocardium, or into engagement with other anatomic structures that impact cardiac output to provide tensile support to the heart muscle wall which resists diastolic filling pressure while simultaneously providing a compressive force to the muscle wall to limit, compensate or provide therapeutic treatment for congestive heart failure and / or to reverse the remodeling that produces an enlarged heart.
Owner:EXTENSIA MEDICAL

Navigation system for cardiac therapies using gating

An image guided navigation system for navigating a region of a patient which is gated using ECG signals to confirm diastole. The navigation system includes an imaging device, a tracking device, a controller, and a display. The imaging device generates images of the region of a patient. The tracking device tracks the location of the instrument in a region of the patient. The controller superimposes an icon representative of the instrument onto the images generated from the imaging device based upon the location of the instrument. The display displays the image with the superimposed instrument. The images and a registration process may be synchronized to a physiological event.
Owner:MEDTRONIC INC

Passive girdle for heart ventricle for therapeutic aid to patients having ventricular dilatation

InactiveUS6224540B1Increased oxygen consumptionLarge increases in the tension-time integralHeart valvesControl devicesVentricular dilatationCardiac muscle
A passive girdle is wrapped around a heart muscle which has dilatation of a ventricle to conform to the size and shape of the heart and to constrain the dilatation during diastole. The girdle is formed of a material and structure that does not expand away from the heart but may, over an extended period of time be decreased in size as dilatation decreases.
Owner:ABIOMED

Systems for heart treatment

InactiveUS20050197692A1Decreasing wall stressReinforce wallSuture equipmentsElectrotherapyLeft ventricular sizeTherapeutic treatment
Described are devices and methods for treating degenerative, congestive heart disease and related valvular dysfunction. Percutaneous and minimally invasive surgical tensioning structures offer devices that mitigate changes in the ventricular structure (i.e., remodeling) and deterioration of global left ventricular performance related to tissue damage precipitating from ischemia, acute myocardial infarction (AMI) or other abnormalities. These tensioning structures can be implanted within various major coronary blood-carrying conduit structures (arteries, veins and branching vessels), into or through myocardium, or into engagement with other anatomic structures that impact cardiac output to provide tensile support to the heart muscle wall which resists diastolic filling pressure while simultaneously providing a compressive force to the muscle wall to limit, compensate or provide therapeutic treatment for congestive heart failure and / or to reverse the remodeling that produces an enlarged heart.
Owner:EXTENSIA MEDICAL

Stress reduction apparatus and method

InactiveUS6908424B2Reduce maximum wall stress experienceRelieve pressureSuture equipmentsHeart valvesCardiac cycleStress reduction
The device and method for reducing heart wall stress. The device can be one which reduces wall stress throughout the cardiac cycle or only a portion of the cardiac cycle. The device can be configured to begin to engage, to reduce wall stress during diastolic filling, or begin to engage to reduce wall stress during systolic contraction. Furthermore, the device can be configured to include at least two elements, one of which engages full cycle and the other which engages only during a portion of the cardiac cycle.
Owner:EDWARDS LIFESCIENCES LLC

Suction detection on an axial blood pump using bemf data

The presence or absence of a suction condition in an implantable blood pump is determined at least in part based on a parameter related to flow, such as a parameter related to thrust on the rotor of the pump. A local extreme of the parameter representing the minimum flow during ventricular diastole in an earlier interval is used to establish a threshold value. A value of the parameter representing the minimum flow during ventricular diastole in a later interval is compared to this threshold. If the comparison indicates a substantial decline in the minimum flow between the earlier and later intervals is associated with a suction condition. During the absence of a suction condition, the threshold is continually updated, so that the system does not indicate presence of a suction condition if the flow decreases gradually.
Owner:HEARTWARE INC

Cardiac reinforcement device

InactiveUS6893392B2Reduce volume sizeReduce diastolic volumeHeart valvesDiagnosticsCardiac wallDiastole
The present disclosure is directed to a cardiac reinforcement device (CRD) and method for the treatment of cardiomyopathy. The CRD provides for reinforcement of the walls of the heart by constraining cardiac expansion, beyond a predetermined limit, during diastolic expansion of the heart. A CRD of the invention can be applied to the epicardium of the heart to locally constrain expansion of the cardiac wall or to circumferentially constrain the cardiac wall during cardiac expansion.
Owner:MARDIL

Paravalvular leak detection, sealing and prevention

The present invention provides a series of new percutaneous concepts of paravalvular repairs including identifying the leak location, several repair techniques and finally built-in means for leak prevention, built on percutaneous valves. A catheter-delivered device locates cavities occurring between a prosthetic valve and the wall of the body vessel where the valve is implanted, the cavities producing paravalvular leaks during diastole, the device comprising at least one of a plurality of flexible wires, the wire having attached to it a balloon, wherein the balloon is pulled by the leak through the cavity and wherein the wire then serves to mark the cavity location.
Owner:EDWARDS LIFESCI PVT

Method and apparatus to unload a failing heart

InactiveUS20070208210A1Lowering LVEDPPrevent of lung congestionElectrocardiographyHeart valvesValved conduitMedicine
A method and apparatus for treatment of heart failure by reducing LV diastolic volume and pressure by pumping blood out of the LV during diastole. A pump is synchronized to the heart cycle, connected to the apex of the LV and discharging into the right atrium of the heart. A left ventricle to aorta one-way valved conduit with added compliance decreases blood pressure in the aorta and the resistance to the ejection of blood by the heart decreases the energy requirements of the heart.
Owner:G&L CONSULTING

System for performing an analysis of pressure-signals derivable from pressure measurements on or in a body

A system for performing an analysis of pressure-signals derivable from pressure measurements on or in a body of a human being or animal, includes a communication interface for receiving a set of digital pressure sample values, a memory for storing these values, and a processor capable of performing the analysis, the processor having means to identify features related to single pressure waves in the pressure signals based on input of the digital data into the processor, and the processor further having determination means which based on the features is configured to a) determine a minimum pressure value related to diastolic minimum value and a maximum pressure value related to systolic maximum value, b) determine at least one parameter of the single wave parameters elected from the group of: pressure amplitude=ΔP=[(maximum pressure value)−(minimum pressure value)], latency (ΔT), rise time or rise time coefficient=ΔP / ΔT, and wavelength of the single wave, c) determine number of the single pressure waves occurring during a given time sequence, including determination of the number of single pressure waves with pre-selected values of one or more of the single pressure wave parameters during the given time sequence, and d) determine number of single pressure waves with pre-selected combinations of two or more of the single pressure wave parameters during the given time sequence. Further, the system has a display for visual presentation of the result of analysis performed by the processor.
Owner:SENSOMETRICS AS (NO)

Passive cardiac assistance device

InactiveUS20030088151A1Large increases in the tension-time integralIncrease consumptionHeart valvesControl devicesLong axisCardiac muscle
Artificial implantable active and passive girdles include a heart assist system with an artificial myocardium employing a number of flexible, non-distensible tubes with the walls along their long axes connected in series to form a cuff and a passive girdle is wrapped around a heart muscle which has dilatation of a ventricle to conform to the size and shape of the heart and to constrain the dilatation during diastole. The passive girdle is formed of a material and structure that does not expand away from the heart but may, over an extended period of time be decreased in size as dilatation decreases.
Owner:ABIOMED

Implantable medical device for measuring ventricular pressure

An implantable medical device has a pressure sensing arrangement to measure right ventricular pressure of a heart including a pressure sensor adapted to be positioned in the right ventricle of the heart, to measure the pressure and to generate a pressure signal in response to the measured pressure. The pressure sensing arrangement also has a pressure signal processor and a timing unit. The processor determines from the pressure signal, using diastolic timing signals from the timing unit based on the pressure signal identifying the diastolic phase, a diastolic pressure signal representing the ventricular pressure only during the diastolic phase of the heart cycle.
Owner:ST JUDE MEDICAL

Antitachycardial pacing

Protocols for antitachycardial pacing including biphasic stimulation administered at, or just above, the diastolic depolarization threshold potential; biphasic or conventional stimulation initiated at, or just above, the diastolic depolarization threshold potential, reduced, upon capture, to below threshold; and biphasic or conventional stimulation administered at a level set just below the diastolic depolarization threshold potential. These protocols result in reliable cardiac capture with a lower stimulation level, thereby causing less damage to the heart, extending battery life, causing less pain to the patient and having greater therapeutic effectiveness. In those protocols using biphasic cardiac pacing, a first and second stimulation phase is administered. The first stimulation phase has a predefined polarity, amplitude and duration. The second stimulation phase also has a predefined polarity, amplitude and duration. The two phases are applied sequentially. Contrary to current thought, anodal stimulation is first applied and followed by cathodal stimulation. In this fashion, pulse conduction through the cardiac muscle is improved together with the increase in contractility.
Owner:MR3 MEDICAL LLC

Progressive biventricular diastolic support device

A device is proposed to progressively reduce the hemodynamic cardiac symptoms of congestive heart failure as well as those induced by dilated cardiomyopathies. This device affords progressive diastolic ventricular control by offering a method for percutaneous access and adjustments of its gas filled bladders surrounding the heart. After opening the pericardium, the device is not attached to the heart muscle but may be anchored to the pericardial sac. The device actually extends primarily around the heart from below the atrio-ventricular canal to the cardiac apex. Between the device exterior, made of non-elastic material and the epicardium, two independent elastic bladders or chambers provide variable compressive diastolic support to the right and left ventricles, while allowing adequate blood flow to the anterior and posterior descending epicardial branches of the coronary arteries and veins. Progressive hemodynamic increases in diastolic pressures for the right and left ventricles can be individually and repeatedly monitored by pressure gauges and an inert gas separately injected or removed in the enclosed chest through self-sealing access ports. These ports are subcutaneously implanted in the left anterior axillary line and connected by thin tubes across the 4th or 5th intercostal spaces to the pericardial bladders or chambers described above.
Owner:ROBERTSON JR ABEL L

Device and method to control volume of a ventricle

ActiveUS7530998B1Small sizePrevent further enlargement of a diseased heartHeart valvesHeart stimulatorsCardiac cycleReverse remodeling
A device used to treat heart disease by decreasing the size of a diseased heart, or to prevent further enlargement of a diseased heart. The device works by limiting the volume of blood entering the heart during each cardiac cycle. The device partitions blood within the heart, and protects the heart from excessive volume and pressure of blood. The device is placed within the interior of the heart, particularly within a ventricular cavity. The device is a hollow sac, with two openings, which simulates the shape and size of the interior lining of a ventricle of a normal heart. It allows the ventricle to fill through one opening juxtaposed to the annulus of the inflow valve to a predetermined, normal volume, and limits filling of the heart beyond that volume. It then allows blood to be easily ejected through the second opening through the outflow valve. By limiting the amount of blood entering the ventricle, the ventricle is not subjected to the harmful effect of excessive volume and pressure of blood during diastole, the period of the cardiac cycle when the heart is at rest. This allows the heart to decrease in size, or to reverse remodel, and to recover lost function. In some applications, a second device may be simultaneously placed inside the heart to take up excessive space between the heart and the primary device.
Owner:STARKEY THOMAS DAVID

Tiltable backboard for cardiopulmonary resuscitation

An apparatus and method to be used in CPR to promote diastolic filling of the heart in cardiac arrest situations during external or internal cardiac compression. A rigid backboard provided with a tilting apparatus to incline the backboard to a desired degree. The backboard can be also provided with a tiltable segment for forward head flexion. The body of a patient victim of cardiac arrest is placed supine over the rigid backboard and the backboard is tilted by actuation of the tilting apparatus to a desired angle thus positioning the patient with feet up and chest down, so that the lower extremities are higher than the abdomen and tilted down toward the abdomen, and the abdomen higher than the chest and tilted down toward the chest. Likewise, being the head flexed forward in respect to the remainder of the body, the head is positioned higher than the heart, and tilted down toward the heart. As a result of such a positioning, the blood in the venous system of the lower extremities, of the abdomen and head will be draining down toward the heart by gravity improving diastolic filling and ultimately will improve cardiac output with internal or external cardiac compressions being carried out with the patient maintained in such position.
Owner:ZADINI FILIBERTO P +1

A heart sound signal quantification analysis method and device

ActiveCN102283670ARealize intelligent identificationRealize quantitative auscultationAuscultation instrumentsSystolic murmurCardiac cycle
The invention discloses a method and a device for quantitatively analyzing heart sound signals. The method comprises the following steps of: acquiring multiple heart sound signals at clinical auscultation positions; preprocessing the acquired multiple heart sound signals; extracting heart sound envelope curves and characteristic parameters of the preprocessed multiple heart sound signals respectively; dividing a systole period in a cardiac cycle of each heart sound signal into a first heart sound period and a systolic murmur period, dividing a diastole period into a second heart sound period and a diastolic murmur period, and computing heart sound energy in all periods respectively; and computing the percentage of the heart sound energy in all the periods in the whole cycle to determine the intensity of normal heart sound and the emergent time and intensity of murmurs. By the method for quantitatively analyzing the heart sound signals, the intensity, the emergent time and the duration time of all components of heart sound can be quantitatively analyzed, and an analysis result can be used as a diagnosis basis for clinical common cardiovascular diseases; and the method and the device are used for evaluating the relationship between cardiac murmur types and the cardiovascular diseases.
Owner:XIHUA UNIV

Device and method to limit filling of the heart

ActiveUS7341584B1Small sizeLimiting volume of bloodHeart valvesSurgical instrument detailsCardiac cycleReverse remodeling
A device used to treat heart disease by decreasing the size of a diseased heart, or to prevent further enlargement of a diseased heart. The device works by limiting the volume of blood entering the heart during each cardiac cycle. The device partitions blood within the heart, and protects the heart from excessive volume and pressure of blood. The device is placed within the interior of the heart, particularly within a ventricular cavity. The device is a hollow sac, with two openings, which simulates the shape and size of the interior lining of a ventricle of a normal heart. It allows the ventricle to fill through one opening juxtaposed to the annulus of the inflow valve to a predetermined, normal volume, and limits filling of the heart beyond that volume. It then allows blood to be easily ejected through the second opening through the outflow valve. By limiting the amount of blood entering the ventricle, the ventricle is not subjected to the harmful effect of excessive volume and pressure of blood during diastole, the period of the cardiac cycle when the heart is at rest. This allows the heart to decrease in size, or to reverse remodel, and to recover lost function. In some applications, a second device may be simultaneously placed inside the heart to take up excessive space between the heart and the primary device.
Owner:STARKEY THOMAS DAVID

Device And A Method For Augmenting Heart Function

A device, a kit and a method are presented for permanently augmenting the pump function of the left heart. The basis for the presented innovation is an augmentation of the physiologically up and down movement of the mitral valve during each heart cycle. By means of catheter technique, minimal surgery, or open heart surgery implants are inserted into the left ventricle, the mitral valve annulus, the left atrium and adjacent tissue in order to augment the natural up and down movement of the mitral valve and thereby increasing the left ventricular diastolic filling and the piston effect of the closed mitral valve when moving towards the apex of said heart in systole and / or away from said apex in diastole.
Owner:SYNERGIO
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products